Immature Platelet Fraction: Establishment of a Reference Interval and Diagnostic Measure for Thrombocytopenia
3
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Immature platelet fraction (IPF, %) is a measure of reticulated platelets (RPs), which represents the state of thrombopoiesis. The IPF is obtained from an automated hematology analyzer as one of the platelet parameters. This study was performed to establish reference intervals of IPF and its cut-off values for the differential diagnosis of thrombocytopenia. Methods: Blood samples from 2,039 healthy individuals (1,161 males, 878 females) were obtained to establish reference intervals. The patient group included patients with idiopathic thrombocytopenic purpura (ITP) (N=150) and aplastic anemia (AA) (N=51) with platelet counts of less than 100×109/L. We evaluated the reliability of the IPF measurements, the reference intervals, and cut-off value for the diagnosis of ITP. Results: The reference intervals of IPF were 0.5-3.2% in males and 0.4-3.0% in females (95% confidence interval). The median IPF% of ITP and AA were 7.7% (range, 1.0-33.8%) and 3.5% (range, 0.6-12.9%), respectively. Statistical analysis revealed a significant difference between the IPF% of ITP and AA (P<0.0001). The cut-off value of IPF for differentiating ITP from AA was 7.3% with a sensitivity and specificity of 54.0% and 92.2%, respectively. Conclusions: A rapid and inexpensive automated measurement of IPF can be integrated as a standard parameter to evaluate the thrombopoietic state of the bone marrow. This study determined the reference intervals of IPF from a large population of healthy individuals, including children. Further studies are needed to establish the clinical utility of IPF. (Korean J Lab Med 2010;30:451-9)
Abstract
Background: Immature platelet fraction (IPF, %) is a measure of reticulated platelets (RPs), which represents the state of thrombopoiesis. The IPF is obtained from an automated hematology analyzer as one of the platelet parameters. This study was performed to establish reference intervals of IPF and its cut-off values for the differential diagnosis of thrombocytopenia. Methods: Blood samples from 2,039 healthy individuals (1,161 males, 878 females) were obtained to establish reference intervals. The patient group included patients with idiopathic thrombocytopenic purpura (ITP) (N=150) and aplastic anemia (AA) (N=51) with platelet counts of less than 100×109/L. We evaluated the reliability of the IPF measurements, the reference intervals, and cut-off value for the diagnosis of ITP. Results: The reference intervals of IPF were 0.5-3.2% in males and 0.4-3.0% in females (95% confidence interval). The median IPF% of ITP and AA were 7.7% (range, 1.0-33.8%) and 3.5% (range, 0.6-12.9%), respectively. Statistical analysis revealed a significant difference between the IPF% of ITP and AA (P<0.0001). The cut-off value of IPF for differentiating ITP from AA was 7.3% with a sensitivity and specificity of 54.0% and 92.2%, respectively. Conclusions: A rapid and inexpensive automated measurement of IPF can be integrated as a standard parameter to evaluate the thrombopoietic state of the bone marrow. This study determined the reference intervals of IPF from a large population of healthy individuals, including children. Further studies are needed to establish the clinical utility of IPF. (Korean J Lab Med 2010;30:451-9)
참고문헌 (30)
- Abe Y, "A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF)", Thromb Res, 118, pp.463~469 (2006)
- Cooper N, "The pathogenesis of immune thrombocytopaenic purpura", Br J Haematol, 133, pp.364~374 (2006)
- Diagnosis and treatment of idiopathic thrombocytopenic purpura, "American Society of Hematology ITP Practice Guideline Panel", Am Fam Physician, 54, pp.2437~2447 (1996)
- Jubelirer SJ, "The role of the bone marrow examination in the diagnosis of immune thrombocytopenic purpura: case series and literature review", Clin Appl Thromb Hemost, 8, pp.73~76 (2002)
- Ancliff PJ, "Trigger factors for prophylactic platelet transfusion", Blood Rev, 12, pp.234~238 (1998)
- Norfolk DR, "Consensus Conference on Platelet Transfusion, Royal College of Physicians of Edinburgh, 27-28 November 1997. Synopsis of background papers", Br J Haematol, 101, pp.609~617 (1997)
- Buttarello M, "Automated blood cell counts: state of the art", Am J Clin Pathol, 130, pp.104~116 (2008)
- Ingram M, "Reticulated platelets following acute blood loss", Br J Haematol, 17, pp.225~229 (1969)
- Briggs C, "Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia", Br J Haematol, 126, pp.93~99 (2004)
- Takubo T, "Usefulness of determining reticulated and large platelets in idiopathic thrombocytopenic purpura", Acta Haematol, 99, pp.109~110 (1998)
- Kienast J, "Flow cytometric analysis of thiazole orange uptake by platelets: a diagnostic aid in the evaluation of thrombocytopenic disorders", Blood, 75, pp.116~121 (1990)
- Robinson MS, "Flow cytometric analysis of reticulated platelets: evidence for a large proportion of non-specific labelling of dense granules by fluorescent dyes", Br J Haematol, 100, pp.351~357 (1998)
- Clinical and Laboratory Standards Institute, "How to define and determine reference intervals in the clinical laboratory: approved guideline. CLSI document C28-A2. 2nd ed" (2008), CLSI
- de Vries RA, "Radioisotopic labels for blood cell survival studies: a review", Nucl Med Biol, 20, pp.809~817 (1993)
- Steinberg MH, "Plasma glycocalicin. An aid in the classification of thrombocytopenic disorders", N Engl J Med, 317, pp.1037~1042 (1987)
- Porcelijn L, "The diagnostic value of thrombopoietin level measurements in thrombocytopenia", Thromb Haemost, 79, pp.1101~1105 (1998)
- Danpure HJ, "The labelling of blood cells in plasma with 111In-tropolonate", Br J Radiol, 55, pp.247~249 (1982)
- Hayashi S, "Comparison of reticulated platelet count with plasma glycocalicin concentration as a marker of platelet turnover in patients with thrombocytopenic disorders", Rinsho Ketsueki, 41, pp.705~711 (2000)
- Steffan A, "Glycocalicin in the diagnosis and management of immune thrombocytopenia", Eur J Haematol, 61, pp.77~83 (1998)
- Harrison P, "Reticulated platelet taskforce report", Lab Hematol, 9, pp.91~ (2003)
- Rinder HM, "Reticulated platelets in the evaluation of thrombopoietic disorders", Arch Pathol Lab Med, 117, pp.606~610 (1993)
- Albanyan A, "Changes in the immature platelet fraction within ageing platelet concentrates", J Thromb Haemost, 6, pp.2213~2215 (2008)
- Briggs C, "Immature platelet fraction measurement: a future guide to platelet transfusion requirement after haematopoietic stem cell transplantation", Transfus Med, 16, pp.101~109 (2006)
- Cesari F, "Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy", Thromb Haemost, 99, pp.930~935 (2008)
- Zucker ML, "Immature platelet fraction as a predictor of platelet recovery following hematopoietic progenitor cell transplantation", Lab Hematol, 12, pp.125~130 (2006)
- Sugimori N, "Aberrant increase in the immature platelet fraction in patients with myelodysplastic syndrome: a marker of karyotypic abnormalities associated with poor prognosis", Eur J Haematol, 82, pp.54~60 (2009)
- Takami A, "Immature platelet fraction for prediction of platelet engraftment after allogeneic stem cell transplantation", Bone Marrow Transplant, 39, pp.501~507 (2007)
- 김혜련, "간경변 환자에서 미성숙 혈소판 분획과 망상혈소판의 비교", The Korean Journal of Laboratory Medicine, 27(1), pp.7~12 (2007), 대한진단검사의학회
- 조용곤, "미성숙혈소판분획을 이용한 혈소판감소증 진단법의 임상적 유용성", The Korean Journal of Laboratory Medicine, 27(1), pp.1~6 (2007), 대한진단검사의학회
- Saigo K, "Automatic detection of immature platelets for decision making regarding platelet transfusion indications for pediatric patients", Transfus Apher Sci, 38, pp.127~132 (2008)